Global Plasma Protein Therapeutics Market Growth 2024-2030
Plasma Protein Therapeutics market grows from US$27.46 billion in 2023 to US$44.25 billion by 2030, with a 7.1% CAGR, driven by increasing demand in the downstream market.
- Bonafide Trust
- 04-01-2024
- Pages : 121
- Figures : 83
- Tables : 139
- Region : Global
- Category : Lifescience
- Pharmaceutical
Plasma protein therapeutics play a vital role in modern medicine, acting as a cornerstone of various medical procedures and treatments. These lifesaving therapies are derived from the liquid portion of human blood, known as plasma. Plasma is a complex biological fluid composed of approximately 92% water and 8% proteins, carbohydrates, fats, vitamins, minerals, and hormones. However, it's the proteins within plasma that hold the key to its therapeutic potential. These proteins number in the thousands, each with a unique structure and specific function within the body.
Through a meticulous process called fractionation, plasma is separated into its constituent parts. Fractionation is akin to meticulously sorting a bag of mixed nuts - each component is carefully isolated and purified. In the context of plasma protein therapeutics, the target components are the proteins. By separating these proteins from other plasma components, scientists and manufacturers can harness their therapeutic potential to create lifesaving medications.
According to our publisher’s latest study, the global Plasma Protein Therapeutics market size was valued at US$ 27460 million in 2023. With growing demand in downstream market, the Plasma Protein Therapeutics is forecast to a readjusted size of US$ 44250 million by 2030 with a CAGR of 7.1% during review period.
What's Inside a Bonafide Research`s industry report?
A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.
Download SampleThe research report highlights the growth potential of the global Plasma Protein Therapeutics market. Plasma Protein Therapeutics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Plasma Protein Therapeutics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Plasma Protein Therapeutics market.
Plasma Protein Therapeutics is use blood products to treat disease.Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called blood product.
Shire (Baxalta), CSL and Grifolsare the leaders of the Plasma Protein Therapeutics industry, which take about 55% market share. China is the major region of the global market, which takes about 45% market share.
Key Features:
The report on Plasma Protein Therapeutics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Plasma Protein Therapeutics market. It may include historical data, market segmentation by Type (e.g., Coagulation Factor, Immune Globulin), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Plasma Protein Therapeutics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Plasma Protein Therapeutics Market Dynamics
The global plasma protein therapeutics market is driven by several key forces:
• Market Drivers:
o Rising chronic diseases: An increase in conditions like cancer and hemophilia fuels demand for these specialized protein therapies.
o Aging population: As people live longer, the need for plasma protein therapies to treat age-related ailments grows.
• Market Trends:
o Technological advancements: Innovations in processing and storage techniques enhance the safety, efficacy, and availability of these therapies.
o Emerging market focus: Developing economies are investing in blood bank infrastructure and promoting blood donation, creating new market potential.
• Market Challenges:
o Plasma shortage: Global demand for plasma proteins often exceeds available supply, especially in developing regions.
o Cost concerns: The high development, manufacturing, and storage costs of these therapies can limit access in some areas.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Plasma Protein Therapeutics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Plasma Protein Therapeutics industry. This include advancements in Plasma Protein Therapeutics technology, Plasma Protein Therapeutics new entrants, Plasma Protein Therapeutics new investment, and other innovations that are shaping the future of Plasma Protein Therapeutics.
• Precision Fractionation: New techniques are enabling more precise separation of plasma components, leading to purer and potentially more effective protein therapies.
• Next-Gen Collection Systems: Automated blood collection systems streamline the donation process, potentially increasing plasma yield and donor comfort.
• Viral Inactivation Techniques: Advanced methods for virus inactivation during plasma processing enhance the safety profile of plasma protein therapeutics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Plasma Protein Therapeutics market. It includes factors influencing customer ' purchasing decisions, preferences for Plasma Protein Therapeutics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Plasma Protein Therapeutics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Plasma Protein Therapeutics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Plasma Protein Therapeutics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Plasma Protein Therapeutics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
• Chronic Disease Burden: Rising prevalence of diseases like cancer and hemophilia fuels demand for these targeted therapies.
• Aging Population: An aging population increases the need for plasma protein therapies in surgeries and treatments for age-related conditions.
• Innovation Pipeline: Advancements in protein engineering and delivery methods can lead to more effective and accessible treatments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Plasma Protein Therapeutics market.
• Combating Chronic Diseases: Rising prevalence of chronic illnesses like immune deficiencies fuels demand for these targeted therapies.
• Silver Lining of Aging: An aging population increases the need for plasma protein treatments for age-related conditions.
• Tech Triumphs: Advancements in blood collection and processing enhance the availability and efficacy of these therapies.
Market Segmentation:
Plasma Protein Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
Coagulation Factor
Immune Globulin
Albumin
Others
Segmentation by application
Hemophilia
PID
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Shire (Baxalta)
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Kamada
Table of Contents
- 1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
- 1.8 Market Estimation Caveats
- 2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Plasma Protein Therapeutics Annual Sales 2019-2030
- 2.1.2 World Current & Future Analysis for Plasma Protein Therapeutics by Geographic Region, 2019, 2023 & 2030
- 2.1.3 World Current & Future Analysis for Plasma Protein Therapeutics by Country/Region, 2019, 2023 & 2030
- 2.2 Plasma Protein Therapeutics Segment by Type
- 2.2.1 Coagulation Factor
- 2.2.2 Immune Globulin
- 2.2.3 Albumin
- 2.2.4 Others
- 2.3 Plasma Protein Therapeutics Sales by Type
- 2.3.1 Global Plasma Protein Therapeutics Sales Market Share by Type (2019-2024)
- 2.3.2 Global Plasma Protein Therapeutics Revenue and Market Share by Type (2019-2024)
- 2.3.3 Global Plasma Protein Therapeutics Sale Price by Type (2019-2024)
- 2.4 Plasma Protein Therapeutics Segment by Application
- 2.4.1 Hemophilia
- 2.4.2 PID
- 2.4.3 Others
- 2.5 Plasma Protein Therapeutics Sales by Application
- 2.5.1 Global Plasma Protein Therapeutics Sale Market Share by Application (2019-2024)
- 2.5.2 Global Plasma Protein Therapeutics Revenue and Market Share by Application (2019-2024)
- 2.5.3 Global Plasma Protein Therapeutics Sale Price by Application (2019-2024)
- 3 Global Plasma Protein Therapeutics by Company
- 3.1 Global Plasma Protein Therapeutics Breakdown Data by Company
- 3.1.1 Global Plasma Protein Therapeutics Annual Sales by Company (2019-2024)
- 3.1.2 Global Plasma Protein Therapeutics Sales Market Share by Company (2019-2024)
- 3.2 Global Plasma Protein Therapeutics Annual Revenue by Company (2019-2024)
- 3.2.1 Global Plasma Protein Therapeutics Revenue by Company (2019-2024)
- 3.2.2 Global Plasma Protein Therapeutics Revenue Market Share by Company (2019-2024)
- 3.3 Global Plasma Protein Therapeutics Sale Price by Company
- 3.4 Key Manufacturers Plasma Protein Therapeutics Producing Area Distribution, Sales Area, Product Type
- 3.4.1 Key Manufacturers Plasma Protein Therapeutics Product Location Distribution
- 3.4.2 Players Plasma Protein Therapeutics Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
- 4 World Historic Review for Plasma Protein Therapeutics by Geographic Region
- 4.1 World Historic Plasma Protein Therapeutics Market Size by Geographic Region (2019-2024)
- 4.1.1 Global Plasma Protein Therapeutics Annual Sales by Geographic Region (2019-2024)
- 4.1.2 Global Plasma Protein Therapeutics Annual Revenue by Geographic Region (2019-2024)
- 4.2 World Historic Plasma Protein Therapeutics Market Size by Country/Region (2019-2024)
- 4.2.1 Global Plasma Protein Therapeutics Annual Sales by Country/Region (2019-2024)
- 4.2.2 Global Plasma Protein Therapeutics Annual Revenue by Country/Region (2019-2024)
- 4.3 Americas Plasma Protein Therapeutics Sales Growth
- 4.4 APAC Plasma Protein Therapeutics Sales Growth
- 4.5 Europe Plasma Protein Therapeutics Sales Growth
- 4.6 Middle East & Africa Plasma Protein Therapeutics Sales Growth
- 5 Americas
- 5.1 Americas Plasma Protein Therapeutics Sales by Country
- 5.1.1 Americas Plasma Protein Therapeutics Sales by Country (2019-2024)
- 5.1.2 Americas Plasma Protein Therapeutics Revenue by Country (2019-2024)
- 5.2 Americas Plasma Protein Therapeutics Sales by Type
- 5.3 Americas Plasma Protein Therapeutics Sales by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
- 6 APAC
- 6.1 APAC Plasma Protein Therapeutics Sales by Region
- 6.1.1 APAC Plasma Protein Therapeutics Sales by Region (2019-2024)
- 6.1.2 APAC Plasma Protein Therapeutics Revenue by Region (2019-2024)
- 6.2 APAC Plasma Protein Therapeutics Sales by Type
- 6.3 APAC Plasma Protein Therapeutics Sales by Application
- 6.4 China
- 6.5 Japan
- 6.6 South Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 China Taiwan
- 7 Europe
- 7.1 Europe Plasma Protein Therapeutics by Country
- 7.1.1 Europe Plasma Protein Therapeutics Sales by Country (2019-2024)
- 7.1.2 Europe Plasma Protein Therapeutics Revenue by Country (2019-2024)
- 7.2 Europe Plasma Protein Therapeutics Sales by Type
- 7.3 Europe Plasma Protein Therapeutics Sales by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 8 Middle East & Africa
- 8.1 Middle East & Africa Plasma Protein Therapeutics by Country
- 8.1.1 Middle East & Africa Plasma Protein Therapeutics Sales by Country (2019-2024)
- 8.1.2 Middle East & Africa Plasma Protein Therapeutics Revenue by Country (2019-2024)
- 8.2 Middle East & Africa Plasma Protein Therapeutics Sales by Type
- 8.3 Middle East & Africa Plasma Protein Therapeutics Sales by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
- 9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
- 10 Manufacturing Cost Structure Analysis
- 10.1 Raw Material and Suppliers
- 10.2 Manufacturing Cost Structure Analysis of Plasma Protein Therapeutics
- 10.3 Manufacturing Process Analysis of Plasma Protein Therapeutics
- 10.4 Industry Chain Structure of Plasma Protein Therapeutics
- 11 Marketing, Distributors and Customer
- 11.1 Sales Channel
- 11.1.1 Direct Channels
- 11.1.2 Indirect Channels
- 11.2 Plasma Protein Therapeutics Distributors
- 11.3 Plasma Protein Therapeutics Customer
- 12 World Forecast Review for Plasma Protein Therapeutics by Geographic Region
- 12.1 Global Plasma Protein Therapeutics Market Size Forecast by Region
- 12.1.1 Global Plasma Protein Therapeutics Forecast by Region (2025-2030)
- 12.1.2 Global Plasma Protein Therapeutics Annual Revenue Forecast by Region (2025-2030)
- 12.2 Americas Forecast by Country
- 12.3 APAC Forecast by Region
- 12.4 Europe Forecast by Country
- 12.5 Middle East & Africa Forecast by Country
- 12.6 Global Plasma Protein Therapeutics Forecast by Type
- 12.7 Global Plasma Protein Therapeutics Forecast by Application
- 13 Key Players Analysis
- 13.1 Shire (Baxalta)
- 13.1.1 Shire (Baxalta) Company Information
- 13.1.2 Shire (Baxalta) Plasma Protein Therapeutics Product Portfolios and Specifications
- 13.1.3 Shire (Baxalta) Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.1.4 Shire (Baxalta) Main Business Overview
- 13.1.5 Shire (Baxalta) Latest Developments
- 13.2 CSL
- 13.2.1 CSL Company Information
- 13.2.2 CSL Plasma Protein Therapeutics Product Portfolios and Specifications
- 13.2.3 CSL Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.2.4 CSL Main Business Overview
- 13.2.5 CSL Latest Developments
- 13.3 Grifols
- 13.3.1 Grifols Company Information
- 13.3.2 Grifols Plasma Protein Therapeutics Product Portfolios and Specifications
- 13.3.3 Grifols Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.3.4 Grifols Main Business Overview
- 13.3.5 Grifols Latest Developments
- 13.4 Octapharma
- 13.4.1 Octapharma Company Information
- 13.4.2 Octapharma Plasma Protein Therapeutics Product Portfolios and Specifications
- 13.4.3 Octapharma Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.4.4 Octapharma Main Business Overview
- 13.4.5 Octapharma Latest Developments
- 13.5 Kedrion
- 13.5.1 Kedrion Company Information
- 13.5.2 Kedrion Plasma Protein Therapeutics Product Portfolios and Specifications
- 13.5.3 Kedrion Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.5.4 Kedrion Main Business Overview
- 13.5.5 Kedrion Latest Developments
- 13.6 LFB Group
- 13.6.1 LFB Group Company Information
- 13.6.2 LFB Group Plasma Protein Therapeutics Product Portfolios and Specifications
- 13.6.3 LFB Group Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.6.4 LFB Group Main Business Overview
- 13.6.5 LFB Group Latest Developments
- 13.7 Biotest
- 13.7.1 Biotest Company Information
- 13.7.2 Biotest Plasma Protein Therapeutics Product Portfolios and Specifications
- 13.7.3 Biotest Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.7.4 Biotest Main Business Overview
- 13.7.5 Biotest Latest Developments
- 13.8 BPL
- 13.8.1 BPL Company Information
- 13.8.2 BPL Plasma Protein Therapeutics Product Portfolios and Specifications
- 13.8.3 BPL Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.8.4 BPL Main Business Overview
- 13.8.5 BPL Latest Developments
- 13.9 RAAS
- 13.9.1 RAAS Company Information
- 13.9.2 RAAS Plasma Protein Therapeutics Product Portfolios and Specifications
- 13.9.3 RAAS Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.9.4 RAAS Main Business Overview
- 13.9.5 RAAS Latest Developments
- 13.10 CBPO
- 13.10.1 CBPO Company Information
- 13.10.2 CBPO Plasma Protein Therapeutics Product Portfolios and Specifications
- 13.10.3 CBPO Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.10.4 CBPO Main Business Overview
- 13.10.5 CBPO Latest Developments
- 13.11 Hualan Bio
- 13.11.1 Hualan Bio Company Information
- 13.11.2 Hualan Bio Plasma Protein Therapeutics Product Portfolios and Specifications
- 13.11.3 Hualan Bio Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.11.4 Hualan Bio Main Business Overview
- 13.11.5 Hualan Bio Latest Developments
- 13.12 Kamada
- 13.12.1 Kamada Company Information
- 13.12.2 Kamada Plasma Protein Therapeutics Product Portfolios and Specifications
- 13.12.3 Kamada Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.12.4 Kamada Main Business Overview
- 13.12.5 Kamada Latest Developments
- 14 Research Findings and Conclusion
List of Tables
Table 1. Plasma Protein Therapeutics Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Plasma Protein Therapeutics Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Coagulation Factor
Table 4. Major Players of Immune Globulin
Table 5. Major Players of Albumin
Table 6. Major Players of Others
Table 7. Global Plasma Protein Therapeutics Sales by Type (2019-2024) & (K Units)
Table 8. Global Plasma Protein Therapeutics Sales Market Share by Type (2019-2024)
Table 9. Global Plasma Protein Therapeutics Revenue by Type (2019-2024) & ($ million)
Table 10. Global Plasma Protein Therapeutics Revenue Market Share by Type (2019-2024)
Table 11. Global Plasma Protein Therapeutics Sale Price by Type (2019-2024) & (USD/Unit)
Table 12. Global Plasma Protein Therapeutics Sales by Application (2019-2024) & (K Units)
Table 13. Global Plasma Protein Therapeutics Sales Market Share by Application (2019-2024)
Table 14. Global Plasma Protein Therapeutics Revenue by Application (2019-2024)
Table 15. Global Plasma Protein Therapeutics Revenue Market Share by Application (2019-2024)
Table 16. Global Plasma Protein Therapeutics Sale Price by Application (2019-2024) & (USD/Unit)
Table 17. Global Plasma Protein Therapeutics Sales by Company (2019-2024) & (K Units)
Table 18. Global Plasma Protein Therapeutics Sales Market Share by Company (2019-2024)
Table 19. Global Plasma Protein Therapeutics Revenue by Company (2019-2024) ($ Millions)
Table 20. Global Plasma Protein Therapeutics Revenue Market Share by Company (2019-2024)
Table 21. Global Plasma Protein Therapeutics Sale Price by Company (2019-2024) & (USD/Unit)
Table 22. Key Manufacturers Plasma Protein Therapeutics Producing Area Distribution and Sales Area
Table 23. Players Plasma Protein Therapeutics Products Offered
Table 24. Plasma Protein Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Plasma Protein Therapeutics Sales by Geographic Region (2019-2024) & (K Units)
Table 28. Global Plasma Protein Therapeutics Sales Market Share Geographic Region (2019-2024)
Table 29. Global Plasma Protein Therapeutics Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global Plasma Protein Therapeutics Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global Plasma Protein Therapeutics Sales by Country/Region (2019-2024) & (K Units)
Table 32. Global Plasma Protein Therapeutics Sales Market Share by Country/Region (2019-2024)
Table 33. Global Plasma Protein Therapeutics Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global Plasma Protein Therapeutics Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas Plasma Protein Therapeutics Sales by Country (2019-2024) & (K Units)
Table 36. Americas Plasma Protein Therapeutics Sales Market Share by Country (2019-2024)
Table 37. Americas Plasma Protein Therapeutics Revenue by Country (2019-2024) & ($ Millions)
Table 38. Americas Plasma Protein Therapeutics Revenue Market Share by Country (2019-2024)
Table 39. Americas Plasma Protein Therapeutics Sales by Type (2019-2024) & (K Units)
Table 40. Americas Plasma Protein Therapeutics Sales by Application (2019-2024) & (K Units)
Table 41. APAC Plasma Protein Therapeutics Sales by Region (2019-2024) & (K Units)
Table 42. APAC Plasma Protein Therapeutics Sales Market Share by Region (2019-2024)
Table 43. APAC Plasma Protein Therapeutics Revenue by Region (2019-2024) & ($ Millions)
Table 44. APAC Plasma Protein Therapeutics Revenue Market Share by Region (2019-2024)
Table 45. APAC Plasma Protein Therapeutics Sales by Type (2019-2024) & (K Units)
Table 46. APAC Plasma Protein Therapeutics Sales by Application (2019-2024) & (K Units)
Table 47. Europe Plasma Protein Therapeutics Sales by Country (2019-2024) & (K Units)
Table 48. Europe Plasma Protein Therapeutics Sales Market Share by Country (2019-2024)
Table 49. Europe Plasma Protein Therapeutics Revenue by Country (2019-2024) & ($ Millions)
Table 50. Europe Plasma Protein Therapeutics Revenue Market Share by Country (2019-2024)
Table 51. Europe Plasma Protein Therapeutics Sales by Type (2019-2024) & (K Units)
Table 52. Europe Plasma Protein Therapeutics Sales by Application (2019-2024) & (K Units)
Table 53. Middle East & Africa Plasma Protein Therapeutics Sales by Country (2019-2024) & (K Units)
Table 54. Middle East & Africa Plasma Protein Therapeutics Sales Market Share by Country (2019-2024)
Table 55. Middle East & Africa Plasma Protein Therapeutics Revenue by Country (2019-2024) & ($ Millions)
Table 56. Middle East & Africa Plasma Protein Therapeutics Revenue Market Share by Country (2019-2024)
Table 57. Middle East & Africa Plasma Protein Therapeutics Sales by Type (2019-2024) & (K Units)
Table 58. Middle East & Africa Plasma Protein Therapeutics Sales by Application (2019-2024) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Plasma Protein Therapeutics
Table 60. Key Market Challenges & Risks of Plasma Protein Therapeutics
Table 61. Key Industry Trends of Plasma Protein Therapeutics
Table 62. Plasma Protein Therapeutics Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Plasma Protein Therapeutics Distributors List
Table 65. Plasma Protein Therapeutics Customer List
Table 66. Global Plasma Protein Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 67. Global Plasma Protein Therapeutics Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Americas Plasma Protein Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 69. Americas Plasma Protein Therapeutics Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. APAC Plasma Protein Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 71. APAC Plasma Protein Therapeutics Revenue Forecast by Region (2025-2030) & ($ millions)
Table 72. Europe Plasma Protein Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Europe Plasma Protein Therapeutics Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Middle East & Africa Plasma Protein Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 75. Middle East & Africa Plasma Protein Therapeutics Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Global Plasma Protein Therapeutics Sales Forecast by Type (2025-2030) & (K Units)
Table 77. Global Plasma Protein Therapeutics Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 78. Global Plasma Protein Therapeutics Sales Forecast by Application (2025-2030) & (K Units)
Table 79. Global Plasma Protein Therapeutics Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 80. Shire (Baxalta) Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 81. Shire (Baxalta) Plasma Protein Therapeutics Product Portfolios and Specifications
Table 82. Shire (Baxalta) Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Shire (Baxalta) Main Business
Table 84. Shire (Baxalta) Latest Developments
Table 85. CSL Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 86. CSL Plasma Protein Therapeutics Product Portfolios and Specifications
Table 87. CSL Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. CSL Main Business
Table 89. CSL Latest Developments
Table 90. Grifols Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 91. Grifols Plasma Protein Therapeutics Product Portfolios and Specifications
Table 92. Grifols Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Grifols Main Business
Table 94. Grifols Latest Developments
Table 95. Octapharma Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 96. Octapharma Plasma Protein Therapeutics Product Portfolios and Specifications
Table 97. Octapharma Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Octapharma Main Business
Table 99. Octapharma Latest Developments
Table 100. Kedrion Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 101. Kedrion Plasma Protein Therapeutics Product Portfolios and Specifications
Table 102. Kedrion Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Kedrion Main Business
Table 104. Kedrion Latest Developments
Table 105. LFB Group Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 106. LFB Group Plasma Protein Therapeutics Product Portfolios and Specifications
Table 107. LFB Group Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. LFB Group Main Business
Table 109. LFB Group Latest Developments
Table 110. Biotest Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 111. Biotest Plasma Protein Therapeutics Product Portfolios and Specifications
Table 112. Biotest Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Biotest Main Business
Table 114. Biotest Latest Developments
Table 115. BPL Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 116. BPL Plasma Protein Therapeutics Product Portfolios and Specifications
Table 117. BPL Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. BPL Main Business
Table 119. BPL Latest Developments
Table 120. RAAS Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 121. RAAS Plasma Protein Therapeutics Product Portfolios and Specifications
Table 122. RAAS Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. RAAS Main Business
Table 124. RAAS Latest Developments
Table 125. CBPO Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 126. CBPO Plasma Protein Therapeutics Product Portfolios and Specifications
Table 127. CBPO Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. CBPO Main Business
Table 129. CBPO Latest Developments
Table 130. Hualan Bio Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 131. Hualan Bio Plasma Protein Therapeutics Product Portfolios and Specifications
Table 132. Hualan Bio Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 133. Hualan Bio Main Business
Table 134. Hualan Bio Latest Developments
Table 135. Kamada Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 136. Kamada Plasma Protein Therapeutics Product Portfolios and Specifications
Table 137. Kamada Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 138. Kamada Main Business
Table 139. Kamada Latest Developments
Table 1. Plasma Protein Therapeutics Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Plasma Protein Therapeutics Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Coagulation Factor
Table 4. Major Players of Immune Globulin
Table 5. Major Players of Albumin
Table 6. Major Players of Others
Table 7. Global Plasma Protein Therapeutics Sales by Type (2019-2024) & (K Units)
Table 8. Global Plasma Protein Therapeutics Sales Market Share by Type (2019-2024)
Table 9. Global Plasma Protein Therapeutics Revenue by Type (2019-2024) & ($ million)
Table 10. Global Plasma Protein Therapeutics Revenue Market Share by Type (2019-2024)
Table 11. Global Plasma Protein Therapeutics Sale Price by Type (2019-2024) & (USD/Unit)
Table 12. Global Plasma Protein Therapeutics Sales by Application (2019-2024) & (K Units)
Table 13. Global Plasma Protein Therapeutics Sales Market Share by Application (2019-2024)
Table 14. Global Plasma Protein Therapeutics Revenue by Application (2019-2024)
Table 15. Global Plasma Protein Therapeutics Revenue Market Share by Application (2019-2024)
Table 16. Global Plasma Protein Therapeutics Sale Price by Application (2019-2024) & (USD/Unit)
Table 17. Global Plasma Protein Therapeutics Sales by Company (2019-2024) & (K Units)
Table 18. Global Plasma Protein Therapeutics Sales Market Share by Company (2019-2024)
Table 19. Global Plasma Protein Therapeutics Revenue by Company (2019-2024) ($ Millions)
Table 20. Global Plasma Protein Therapeutics Revenue Market Share by Company (2019-2024)
Table 21. Global Plasma Protein Therapeutics Sale Price by Company (2019-2024) & (USD/Unit)
Table 22. Key Manufacturers Plasma Protein Therapeutics Producing Area Distribution and Sales Area
Table 23. Players Plasma Protein Therapeutics Products Offered
Table 24. Plasma Protein Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Plasma Protein Therapeutics Sales by Geographic Region (2019-2024) & (K Units)
Table 28. Global Plasma Protein Therapeutics Sales Market Share Geographic Region (2019-2024)
Table 29. Global Plasma Protein Therapeutics Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global Plasma Protein Therapeutics Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global Plasma Protein Therapeutics Sales by Country/Region (2019-2024) & (K Units)
Table 32. Global Plasma Protein Therapeutics Sales Market Share by Country/Region (2019-2024)
Table 33. Global Plasma Protein Therapeutics Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global Plasma Protein Therapeutics Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas Plasma Protein Therapeutics Sales by Country (2019-2024) & (K Units)
Table 36. Americas Plasma Protein Therapeutics Sales Market Share by Country (2019-2024)
Table 37. Americas Plasma Protein Therapeutics Revenue by Country (2019-2024) & ($ Millions)
Table 38. Americas Plasma Protein Therapeutics Revenue Market Share by Country (2019-2024)
Table 39. Americas Plasma Protein Therapeutics Sales by Type (2019-2024) & (K Units)
Table 40. Americas Plasma Protein Therapeutics Sales by Application (2019-2024) & (K Units)
Table 41. APAC Plasma Protein Therapeutics Sales by Region (2019-2024) & (K Units)
Table 42. APAC Plasma Protein Therapeutics Sales Market Share by Region (2019-2024)
Table 43. APAC Plasma Protein Therapeutics Revenue by Region (2019-2024) & ($ Millions)
Table 44. APAC Plasma Protein Therapeutics Revenue Market Share by Region (2019-2024)
Table 45. APAC Plasma Protein Therapeutics Sales by Type (2019-2024) & (K Units)
Table 46. APAC Plasma Protein Therapeutics Sales by Application (2019-2024) & (K Units)
Table 47. Europe Plasma Protein Therapeutics Sales by Country (2019-2024) & (K Units)
Table 48. Europe Plasma Protein Therapeutics Sales Market Share by Country (2019-2024)
Table 49. Europe Plasma Protein Therapeutics Revenue by Country (2019-2024) & ($ Millions)
Table 50. Europe Plasma Protein Therapeutics Revenue Market Share by Country (2019-2024)
Table 51. Europe Plasma Protein Therapeutics Sales by Type (2019-2024) & (K Units)
Table 52. Europe Plasma Protein Therapeutics Sales by Application (2019-2024) & (K Units)
Table 53. Middle East & Africa Plasma Protein Therapeutics Sales by Country (2019-2024) & (K Units)
Table 54. Middle East & Africa Plasma Protein Therapeutics Sales Market Share by Country (2019-2024)
Table 55. Middle East & Africa Plasma Protein Therapeutics Revenue by Country (2019-2024) & ($ Millions)
Table 56. Middle East & Africa Plasma Protein Therapeutics Revenue Market Share by Country (2019-2024)
Table 57. Middle East & Africa Plasma Protein Therapeutics Sales by Type (2019-2024) & (K Units)
Table 58. Middle East & Africa Plasma Protein Therapeutics Sales by Application (2019-2024) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Plasma Protein Therapeutics
Table 60. Key Market Challenges & Risks of Plasma Protein Therapeutics
Table 61. Key Industry Trends of Plasma Protein Therapeutics
Table 62. Plasma Protein Therapeutics Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Plasma Protein Therapeutics Distributors List
Table 65. Plasma Protein Therapeutics Customer List
Table 66. Global Plasma Protein Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 67. Global Plasma Protein Therapeutics Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Americas Plasma Protein Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 69. Americas Plasma Protein Therapeutics Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. APAC Plasma Protein Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 71. APAC Plasma Protein Therapeutics Revenue Forecast by Region (2025-2030) & ($ millions)
Table 72. Europe Plasma Protein Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Europe Plasma Protein Therapeutics Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Middle East & Africa Plasma Protein Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 75. Middle East & Africa Plasma Protein Therapeutics Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Global Plasma Protein Therapeutics Sales Forecast by Type (2025-2030) & (K Units)
Table 77. Global Plasma Protein Therapeutics Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 78. Global Plasma Protein Therapeutics Sales Forecast by Application (2025-2030) & (K Units)
Table 79. Global Plasma Protein Therapeutics Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 80. Shire (Baxalta) Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 81. Shire (Baxalta) Plasma Protein Therapeutics Product Portfolios and Specifications
Table 82. Shire (Baxalta) Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Shire (Baxalta) Main Business
Table 84. Shire (Baxalta) Latest Developments
Table 85. CSL Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 86. CSL Plasma Protein Therapeutics Product Portfolios and Specifications
Table 87. CSL Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. CSL Main Business
Table 89. CSL Latest Developments
Table 90. Grifols Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 91. Grifols Plasma Protein Therapeutics Product Portfolios and Specifications
Table 92. Grifols Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Grifols Main Business
Table 94. Grifols Latest Developments
Table 95. Octapharma Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 96. Octapharma Plasma Protein Therapeutics Product Portfolios and Specifications
Table 97. Octapharma Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Octapharma Main Business
Table 99. Octapharma Latest Developments
Table 100. Kedrion Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 101. Kedrion Plasma Protein Therapeutics Product Portfolios and Specifications
Table 102. Kedrion Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Kedrion Main Business
Table 104. Kedrion Latest Developments
Table 105. LFB Group Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 106. LFB Group Plasma Protein Therapeutics Product Portfolios and Specifications
Table 107. LFB Group Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. LFB Group Main Business
Table 109. LFB Group Latest Developments
Table 110. Biotest Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 111. Biotest Plasma Protein Therapeutics Product Portfolios and Specifications
Table 112. Biotest Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Biotest Main Business
Table 114. Biotest Latest Developments
Table 115. BPL Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 116. BPL Plasma Protein Therapeutics Product Portfolios and Specifications
Table 117. BPL Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. BPL Main Business
Table 119. BPL Latest Developments
Table 120. RAAS Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 121. RAAS Plasma Protein Therapeutics Product Portfolios and Specifications
Table 122. RAAS Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. RAAS Main Business
Table 124. RAAS Latest Developments
Table 125. CBPO Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 126. CBPO Plasma Protein Therapeutics Product Portfolios and Specifications
Table 127. CBPO Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. CBPO Main Business
Table 129. CBPO Latest Developments
Table 130. Hualan Bio Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 131. Hualan Bio Plasma Protein Therapeutics Product Portfolios and Specifications
Table 132. Hualan Bio Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 133. Hualan Bio Main Business
Table 134. Hualan Bio Latest Developments
Table 135. Kamada Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 136. Kamada Plasma Protein Therapeutics Product Portfolios and Specifications
Table 137. Kamada Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 138. Kamada Main Business
Table 139. Kamada Latest Developments
Related Reports
One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. Read More
One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. Read More
Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. Read More
All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). Read More
Safe and Secure SSL Encrypted
Quick Contacts
Want to customize this report?
We offer 10% Free Customization at the time of purchase
Get Free Customization.png "Nikita Jabrela")
Trusted Partners
Budget constraints? Get in touch with us for special pricing
Request DiscountOrder Detail
- Order Placed (21 March, 2025)
- Notify To Team (21 March, 2025)
- Report updation (22 March, 2025)
- Report Quality Check (22 March, 2025)
- Report Dispatch (23 March, 2025)
- Hard Copy
Recently Viewed Products
Global Plasma Protein Therapeutics Market Growth 2024-2030
We are friendly and approachable, give us a call.